Summary
Torrent Pharmaceuticals (TRP) has signed definitive agreements to acquire a 49.2% controlling stake in JB Chemicals and Pharmaceuticals (JBCP) for ₹126.4 billion and plans to acquire the remaining 50.8% through a share swap valued at ₹140.4 billion. This results in a total enterprise value of ₹266.3 billion, marking Torrent's largest acquisition to date.
The deal makes TRP the 5th-largest pharma company in India, with a stronger presence in cardiac, gastro, ophthalmology, nephrology, and CDMO segments. Execution will be key, given the scale, complexity, and integration risks.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
